Condition: Non-small Cell Lung Cancer · Metastatic Non-Small Cell Lung Cancer · NSCLC · Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
A first in human study to evaluate the safety and preliminary antitumor activity of BBO-8520, a KRAS G12C (ON and OFF) inhibitor, as a single agent and in combination with pembrolizumab and BBO-10203 in subjects with locally advanced and unresectable or metastatic non-small cell lung cancer with a KRAS (Kirsten rat sarcoma) G12C mutation.
This description comes directly from the study's public registry record.
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics) · 650-405-8440 · onkoras-101ct.gov@bridgebiooncology.com
Always discuss trial participation with your own doctor first.
| O'Neal Comprehensive Cancer Center at UAB | Birmingham, Alabama, United States | Recruiting |
| University of California - San Diego Moores Cancer Center | La Jolla, California, United States | Recruiting |
| University of California San Francisco | San Francisco, California, United States | Recruiting |
| UCLA Health - Santa Monica Cancer Care | Santa Monica, California, United States | Recruiting |
| University of Colorado Cancer Center | Aurora, Colorado, United States | Recruiting |
| Yale Cancer Center | New Haven, Connecticut, United States | Recruiting |
| Norwalk Hospital | Norwalk, Connecticut, United States | Recruiting |
| OSF Saint Francis Medical Center | Peoria, Illinois, United States | Recruiting |
| University of Kansas Medical Center | Kansas City, Kansas, United States | Recruiting |
| Henry Ford Cancer - Detroit | Detroit, Michigan, United States | Recruiting |
| Roswell Park Cancer Institute | Buffalo, New York, United States | Recruiting |
| Perlmutter Cancer Center - NYU Langone Health | New York, New York, United States | Recruiting |
+ 23 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06343402